- Philstar.com
- The Philippine Star
- Pilipino Star Ngayon
- The Freeman
- Pang-Masa
- Banat
- Interaksyon
- Coupons
Array ( [results] => Array ( [0] => Array ( [ArticleID] => 663193 [Title] => FDA review backs ezetimibe and simvastatin combination [Summary] =>After a year-long review of data from the ENHANCE trial that showed no significant difference in the changes in carotid artery thickness between patients treated with ezetimibe and simvastatin, vs. simvastatin alone, the Food and Drug Administration has concluded that patients should not stop taking ezetimibe/simvastatin or any cholesterol-lowering medications.
[DatePublished] => 2011-03-06 00:00:00 [ColumnID] => 136231 [Focus] => 0 [AuthorID] => 1805110 [AuthorName] => Charles C. Chante MD [SectionName] => Opinion [SectionUrl] => opinion [URL] => ) ) )
ATHEROSCLEROTIC PROCESS
Array ( [results] => Array ( [0] => Array ( [ArticleID] => 663193 [Title] => FDA review backs ezetimibe and simvastatin combination [Summary] =>After a year-long review of data from the ENHANCE trial that showed no significant difference in the changes in carotid artery thickness between patients treated with ezetimibe and simvastatin, vs. simvastatin alone, the Food and Drug Administration has concluded that patients should not stop taking ezetimibe/simvastatin or any cholesterol-lowering medications.
[DatePublished] => 2011-03-06 00:00:00 [ColumnID] => 136231 [Focus] => 0 [AuthorID] => 1805110 [AuthorName] => Charles C. Chante MD [SectionName] => Opinion [SectionUrl] => opinion [URL] => ) ) )
abtest
EZ2 - 9 25
SUERTRES - 90 4
6D Lotto - 6 6 5 5 2 1
6/42 Lotto - 40 2 33 21 14 36
P5,940,000.00
6/49 Super Lotto - 49 7 32 26 40 48
P110,373,908.00
- 12:00 am